Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-10-21

Clinical Trial Update: Bioburden Reduction of Diabetic Foot Ulcer [Phase 1]

View source ↗

Summary

This update covers a Phase 1 clinical trial conducted by Nomir Medical Technologies evaluating bioburden reduction for diabetic foot ulcers. The trial status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nomir Medical Technologies | Conditions: Diabetic Foot Ulcer | Phase 1 | Status: UNKNOWN